Our IHC analysis revealed that elafin was consistently expressed by the normal mammary epithelium, but downregulated in 24% of DCIS and 83% of invasive breast carcinoma specimens (Figure 1C). This evidence concerns the gene PI3 and invasive breast carcinoma.